28
Views
48
CrossRef citations to date
0
Altmetric
Original Article

The Immunoregulatory Disturbance in Autoimmune Thyroid Disease

Pages 55-72 | Received 12 Mar 1988, Published online: 07 Jul 2009

References

  • Volpé R. Autoimmune thyroid disease. Autoimmunity in endocrine disease, R. Volpé. Marcel Dekker, New York 1985; 109–285
  • Volpé R. Autoimmune thyroid disease - a perspective. Mol Biol Med 1986; 3: 25–51
  • Hashimoto H. Zur Kenntnis der Lymphomatosen Veranderung der Schildruse (Strume Lymphomatosa). Arch Klin Chir 1912; 97: 219–248
  • Loeb P D, Drash A L, Kenny FM. Prevalence of low titer and “negative” antithyroglobulin antibodies in biopsy-proven juvenile Hashimoto's thyroiditis. J Pediatr 1973; 82: 17–21
  • Amino H, Miyai K. Postpartum autoimmune endocrine syndrome. Autoimmune endocrine disease, T. F. Davies. Wiley-Interscience, New York 1983; 247–272
  • Okita N, Row V V, Volpé R. Suppressor T lymphocyte deficiency in Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 1981; 52: 528–533
  • Okita N, How J, Topliss D, Lewis M, Row V V, Volpé R. Suppressor T lymphocyte dysfunction in Graves' disease: role of H-2 histamine receptor-bearing suppressor T lymphocytes. J Clin Endocrinol Metab 1981; 53: 1002–1007
  • Topliss D J, Okita N, Lewis M, Row V V, Volpé R. Allosuppressor T lymphocytes abolish migration inhibition factor production in autoimmune thyroid disease: evidence from radio-sensitivity experiments. Clin Endocrinol 1981; 15: 335–341
  • Topliss D J, How J, Lewis M, Row V V, Volpé R. Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus. J Clin Endocrinol Metab 1983; 57: 700–705
  • How J, Topliss D J, Strakosch C, Lewis M, Row V V, Volpé R. T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves' disease. Clin Endocrinol 1983; 18: 61–72
  • Benveniste P, Row V V, Volpé R. Studies on the immuno-regulation of thyroid autoantibody production in vitro. Clin Exper Immunol 1985; 61: 274–282
  • Row V V, Volpé R. In vitro regulation of antithyroglobulin synthesis by lymphocytes of patients with Hashimoto's disease by an antigen-specific suppressor factor derived from cultures of normal human T lymphocytes. J Clin Lab Immunol 1986; 21: 159–163
  • Iitaka M, Aguayo J, Row V V, Volpé R. Studies of the suppressor T cell function in the induction of antithyroid microsomal antibody secreting cells. J Clin Endocrinol Metab 1988; 66: 708–714
  • Vento S, Hegarty J E, Bottazzo G F, Macchia E, Williams R, Eddleston A LWF. Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet 1984; 1: 1200–1204
  • Vento S, O'Brien C J, Condy T, Williams R, Eddleston A LWF. Is cellular immunity to the TSH receptor restricted to patients with Graves' disease. The thyroid autoimmunity, H. A. Drexhage, W. M. Wiersigna. Excerpta Medica International Congress Series 711, Elsevier Science Publishers, Amsterdam 1986; 304–305
  • Noma T, Yata J, Shishiba Y, Inatsuki B. In vitro detection of antithyroglobulin antibody forming cells from the lymphocytes of chronic thyroiditis patients. An analysis of their regulation. Clin Exper Immunol 1982; 49: 565–571
  • Noma T, Kawano Y, Sasazuki T, Yata J. Properties of suppressor T cell factor regulating antithyroglobulin antibody formation in the lymphocytes of chronic thyroiditis patients. Proceedings of the Sixth International Congress of Immunology, Toronto, July 6–11, 1986, Abstract No. 3.47.12 (Published by the National Research Council of Canada, Ottawa, NRCC, 15710 ISBN 0–660–53282–4)
  • Tao T W, Gatenby P A, Leu S L, Pham H, Kriss JP. Helper and suppressor activities of lymphocyte subsets on anti-thyroglobulin products in vitro. J Clin Endocrinol Metab 1985; 61: 520–524
  • Mori H, Hamada N, DeGroot LJ. Studies on thyroglobulin-specific suppressor T cell function in autoimmune thyroid disease. J Clin Endocrino Metab 1985; 60: 306–312
  • Balasz CS, Stenzsky V, Kozman L, Farid NR. Specific suppressor T cell function in a patient with Graves' disease and her healthy identical twin. Clin Endocrinol 1984; 20: 683–693
  • Volpé R, Edmonds M W, Clarke P V, Row VV. A viewpoint regarding the nature of the emergence of long acting thyroid stimulator of Graves' disease. Acta Endocrinol Panamer 1970; 1: 155–170
  • Volpé R, Edmonds M W, Lamki L, Clarke P W, Row VV. The pathogenesis of Graves' disease. A disorder of delayed hypersensitivity. Mayo Clin Proc 1972; 47: 824–834
  • Wick G. Concept of a multigenic basic for the pathogenesis of spontaneous autoimmune thyroiditis. Acta Endocrinol. (Copenhagen) 1987; 115: 63–69, (suppl. 281)
  • Wick G, Graf J. Electron microscopic studies in chickens of the obese strain with spontaneous hereditary autoimmune thyroiditis. Lab Invest 1972; 27: 400–411
  • Kahn L D, Dale J. Virus like particles in Hashimoto's disease and a variety of other tissues. Lab Invest 1973; 29: 350–351
  • Bottazzo G F, Mirakian R, De Lazzari F, Mauerhoff T, Todd I, Pujol-Borrell R. Autoimmune endocrine/organ specific disorders: Clinical diagnostic relevance and novel approach to pathogenesis. Hormones and Immunity, I Berczi, K. Kovacs. MTP Press, Norwell, Massachusetts 1977; 296–311
  • Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2: 1115–1119
  • Belfiore A, Pujol-Borrell R, Mauerhoff T, Mirakian R, Bottazzo GF. Effects of SV-40 transformation on HLA-expression by thyroid follicular cells. Ann d'Endocrinol 1986; 47: 17, Abstract
  • Neufeld B S, Platzer M, Davies TF. Viral induction of thyroid cell MHC Class II gene expression. Proc. of the American Thyroid Association, Washingtion, DC September 16–19, 1987, Abstract No. 34
  • Londei M, Lamb J R, Bottazzo G F, Feldmann M. Epithelial cells expressing aberrant MHC Class II determinants can present antigen to cloned human T cells. Nature 1986; 312: 639–641
  • Iwatani Y, Gerstein H C, Iitaka M, Row V V, Volpé R. Thyrocyte HLA-DR expression and interferon gamma production in autoimmune thyroid disease. J Clin Endocrinol Metabl 1986; 63: 695–708
  • Mowat WM. Interferon and Class II MHC antigen expression in autoimmunity. Lancet 1985; 2: 283
  • Grubeck-Loebenstein B, Onvi M, Greenall C, Pirich K, Waldhausl W, Feldmann F. Stimulatory activities of antigen presenting cells in mixed leukocyte reactions in thyroid diseases. Acta Endocrinol 1987; 115: 89–422, (Supplement 281)
  • Davies TF. Cocultures of human thyroid monolayer cells and autologous T cells: impact of HLA Class II antigen expression. J Clin Endorcinol Metab. 1985; 61: 418–422
  • Leclère J, Faure C, Bene M C, Thomas J L, Paul J L, Hertemann P. Insitu immunological disorders in DeQuervain's thyroditis. Medeiros Neto G and Gaitan E, Frontiers in thyroidology. Plenum Press, New York 1986; Vol. II: 1365–1368
  • Leclére J, Bene M C, Duprez A, Faure G, Thomas J L, Vitnaud J M, Burlet C. Behaviour of thyroid tissue from patients with Graves' disease in nude mice. J Clin Endocrinol Metabl 1984; 59: 175–177
  • Usadel K H, Teuber J, Paschke R, Junker M, Schwedes U. Transplantation of human endocrine tissue to nude mice; a suitable in vivo model for the study of pathomechanisms involved in autoimmune thyroid disease. Acta Endocrinol 1987; 115: 77–81, (Supplement 281)
  • Schumm-Draeger P M, Usadel K H, Bohm B, Wenisch H JC, Senekowitsch R, Pickardt C R, Schoffling K. Thyrotoxic effects of high iodine doses on xenotransplanted autoimmune thyroid tissue in athymic nude mice. Acta Endocrinol 1987; 115: 118–124, (Supplement 281)
  • Bech K, Nerup J, Larsen HH. Yersinia enterocolitica infection and thyroid disease. Acta Endocrinol 1977; 84: 87–92
  • Bech K, Clemmensen O, Larsen J H, Bendixen J. Thyroid disease and. Yersinia. Lancet 1977; 1: 1060–1061
  • Shenkman L, Bottone EJ. Antibodies to Yersinia enterocolitica in thyroid disease. Ann Intern Med 1976; 85: 735–739
  • Safran M, Paul T L, Roti E, Braverman L. Environmental factors affecting autoimmune thyroid disease. Autoimmune thyroid diseae, JR Wall. Endocrinology and Metabolism Clinics of North America. 1987; 16: 327–342
  • Wenzel B E, Heesemann J, Wenzel K W, Scriba PC. Antibodies to plasmid encoated proteins of enteropathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1988; 1: 56
  • Adams DD. Protection from autoimmune disease as the third function of the major histocompatibility gene complex. Lancet 1987; 2: 245–249
  • Knight A, Adams DD. Lack of allotypic variations in the autoantigen for the thyroid stimulating antibody. Clin Exper Immunol 1983; 52: 317–324
  • Hamada N, Yamakawa J, Hinotani A, Okamato Y, Ohno M, Mori H, Noh J, Ito K, Portman L. Thyroid microsomal antigen in Graves' thyroid is not different from normal thyroid. Proc. 62nd Meeting of the American Thyroid Association, Washington, DC, September 16–19, 1987, Abstract No. 90
  • Von Westarp C, Knox A JS, Row V V, Volpe R. Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long acting thyroid stimulation for thyroid binding. Acta Endocrinol (Copenhagen) 1977; 84: 759–769
  • Adams DD. Graves' disease. A paradigm for autoimmunity. Thyroid autoimmune disease, A. Pinchera. Plenum Press, London 1988, in press
  • Logtemberg T, Kroon A, Gmelig-Meyling FHJ, Ballieux RE. Antigen and mitogen induced differentiation of circulating B cells in patients with autoimmune thyroid disease and normal individuals. The thyroid and autoimmunity, HA Drexhage, WM. Wiersing. Excerpta Medica International Congress Series 711, Elesvier, Amsterdam 1986; 308–310
  • Iwatani Y, Iitaka M, Row V V, Volpé R. Induction of thyroid autoantibody production: synergistic effect of B cells mitogen combined with T cell mitogen. J Clin Endocrinol Metab 1987; 65: 853–861
  • Hara Y, Satoh K, Tanikawa T, Sakatsume Y, Ishii J, DeGroot LJ. Spontaneous in vitro production of thyroglobulin specific helper factor in patients with autoimmune thyroid disease. J Clin Lab Immunol 1987; 22: 107–112
  • Jones D M, Teng C S, Yeung R. Evaluation of B cells, T helper cells and suppressor cell function in patients with Graves' disease before and after treatment with antithyroid drugs. Clin Immunol Immunopathol 1982; 25: 232–242
  • DeBernardo E, Davies TF. Functional aspect of B cell autonomy of human thyroid disease. Life Sciences 1983; 32: 139–152
  • McGregor A M, Petersen A M, McLachlan S M, Rooke P, Rees Smith B, Hall R. Carbimazole and the autoimmune response in Graves' disease. New Engl J Med 1982; 303: 302–307
  • Totterman T H, Karlsson F A, Bengtsson M, Mendel-Hertvig I. Induction of the circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. New Engl J Med 1987; 316: 15–22
  • Volpé R. Immunoregulation in autoimmune thyroid disease. New Endl J Med 1987; 316: 44–46
  • Volpé R, Karlsson A, Jansson R, Dahlberg PA. Thyrostatic drugs act through modulation of thyroid cell activity to induce remissions in Graves' disease. Acta Endocrinol (Copenhagen) 1987; 115: 305–311, (Supplement 218)
  • Aguayo J, Michaud P, Iitaka M, DeGroot L J, Row V V, Volpé R. Expression of thyroid peroxidase and thyroglobulin antigen release by cultured human thyrocytes. Effect of methimazole. Proc. of the American Thyroid Association, Washington, DC, September 16–19, 1987, Abstract No 91
  • Chan J YC, Walfish PG. Activated (IA +) T lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry. J Clin Endocrinol Metab 1986; 62: 403–409
  • Ludgate M E, McGregor A M, Weetman A P, Ratanachaiyovong S, Lazarus J H, Middleton GH. Analysis of T cell subsets in Graves' disease. Alteration associated with carbimazole. Brit Med J 1984; 228: 526–530
  • Karlsson F A, Totterman R H, Mendel-Hartwig I. Alterations in HLA-DR expressing T cell subsets during treatment of Graves' disease. Frontiers in thyroidology, G Medeiros Neto, E. Gaitan. Plenum Press, New York 1985; Vol. II: 1555–1557
  • Londei M, Bottazzo G F, Feldmann M. Human T cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
  • Kaulferssh W, Waldmann T A, Baker JR. Immunoglobulin and T cell gene rearrangements demonstrate that the immune response in autoimmune thyroid disease is polyclonal in nature. Proc. of the American Thyroid Association, Washington, DC, September 16–19, 1987, Abstract 89
  • Beall G N, Kruger SR. Production of human antithyroglobulin in vitro II. Regulation by T cells. Clin Immunol Immunopathol 1980; 16: 498–503
  • Dehee D H, Edginton TS. Evidence for a B lymphocyte defect underlying the anti-X antierythrocyte autoantibody response of NZB mice. J Immunol 1977; 118: 1859–1864
  • Green D R, Flood P M, Gershon RK. Immunoregulatory T cell pathways. Ann Rev Immunol 1983; 1: 439–452
  • Smith H R, Green D R, Smathers P A, Gershon R K, Reveche E S, Steinberg AD. Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cells activators. Association with contra-suppressor function. Clin Exper Immunol 1983; 51: 579–585
  • Morimoto C, Steingberg A D, Letvin N I, Nagen M, Takeuchi T, Daley J, Levine H, Scholssman SF. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated by anti-2H4 antibodies. J Clin Invest 1987; 79: 762–766
  • Ludgate M E, Ratanachaiyovong S, Weetman A P, Hall R, McGregor AM. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Grave's disease using in vitro assay of lymphokine mediating migration inhibition. J Clin Endocrinol Metab 1985; 60: 98–102
  • Corazza G R, Sachielli P, Londei M, Frisoni M, Gasparini G. Gluten specific suppressor T cell function in coeliac disease. Gut 1986; 27: 392–398
  • Ueki Y, Eguchi K, Fukuda T, Otsuba T, Kawabe Y, Shimonura C, Matsunaga M, Tezuka H, Ishikawa N, Ito K, Nagataki S. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease. J Clin Endocrinol Metabl 1987; 65: 922–928
  • Davies T F, Platzer M. The T cell suppressor defect in autoimmune thyroiditis: evidence for a high set “immunostat”. Clin Exper Immunol 1986; 63: 73–78
  • Ahmann A J, Burman KD. The role of T lymphocytes in autoimmune thyroid disease. Autoimmune thyroid disease, JR Wall, 1987; 16: 287–326, Endocrinology and Metabolism Clinics of North America
  • Torfs C P, King M C, Huey V, Malmgren J, Grumet FC. Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid disease and rheumatoid arthritis. Amer J Human Genet 1986; 38: 170–187
  • Volpé R, Row VV. Role of antigen specific suppressor T lymphocytes in the pathognesis of autoimmune thyroid disease. Autoimmunity and the thyroid, PG Walfish, JR Wall, R. Volpé. Academic Press, Florida 1984; 79–94
  • Gerstein H C, Rastogi B, Iwatani Y, Iitaka M, Row V V, Volpé R. The decrease in non-specific suppressor T lymphocytes in female hyperthryoid Graves' disease is secondary to the hyperthyroidism. Clin Invest Med 1987; 10: 377–344
  • Van der Gaag R D, VonBlomerg-Van der Flier M, Van der Plassche-Bores E, Kokje-Kleingeld M, Drexhage HA. T suppressor cell defects in euthroid non-endemic goitre. Acta Endocrinol (Copenhagen) 1986; 112: 83–88
  • Weetman A P, McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocr Rev 1984; 5: 309–355
  • Papac M, Stein-Streilein J, Zakarija M, McKenzie J M, Guffee F, Fletcher MA. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest 1987; 79: 404–408
  • Gray J, Hoffenberg R. Thyrotoxicosis and stress. Quart J Med 1985; 54: 153–160
  • Editorial. Emotion and immunity. Lancet 1985; 2: 133–134
  • Paschke R, Tueber J, Schwedes U, Usadel KH. Is remission of Graves' disease regulated by anti-idiotypic antibodies. Acta Endocrinol 1987; 115: 99–103, (Supplement 281)
  • Raines K B, Baker J R, Lukes Y G, Wartofsky L, Burman KD. Antithyrotropin antibodies in the sera of Graves' disease patients. J Clin Endocrinol Metab 1985; 61: 217–222
  • Thomas M AB, Williams DG. Idotypes and antiidiotypic antibodies in health and disease. Quart J Med 1987; 247: 883–888, New Series 65
  • Zakarija M, McKenzie J M, Hoffman WH. Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab 1986; 62: 368–371
  • Aguayo J, Iitaka M, Row V V, Volpé R. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon gamma induced HLA-DR expression. J Clin Endocr Metab 1988; 66, in press

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.